TerrAscend (TSNDF) Treasury Shares (2020 - 2026)
TerrAscend's (TSNDF) quarterly Treasury Shares came in at $9.8 million in Q1 2026, up 537.96% year-on-year from $1.5 million in Q1 2025, and up 95.06% on a QoQ basis from $5.0 million in Q4 2025.
TerrAscend (TSNDF) Treasury Shares (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 7 years of Treasury Shares data on file, last reported at $9.8 million in Q1 2026.
- On a quarterly basis, Treasury Shares rose 537.96% year-over-year to $9.8 million in Q1 2026; TTM through Mar 2026 was $9.8 million, a 537.96% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, up 214.27% from the prior year.
- Treasury Shares for Q1 2026 stood at $9.8 million, up from $5.0 million in the prior quarter.
- Over the last five years, Treasury Shares for TSNDF reached as high as $9.8 million in Q1 2026 and fell as low as $129500.0 in Q4 2024.
- Historically, Treasury Shares has averaged $2.7 million across 5 years, with a median of $1.5 million in 2025.
- Across the five-year window, Treasury Shares plunged 87.99% in 2024 and surged 3783.64% in 2025, its largest moves.
- Year by year, Treasury Shares stood at $415640.0 in 2022, then soared by 159.5% to $1.1 million in 2023, then plunged by 87.99% to $129500.0 in 2024, then jumped by 3783.64% to $5.0 million in 2025, then soared by 95.06% to $9.8 million in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $9.8 million in Q1 2026, $5.0 million in Q4 2025, and $8.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 9.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.81 Mn |
| Mar 31, 2026 | 9.81 Mn |
| Dec 31, 2025 | 5.03 Mn |
| Dec 31, 2025 | 5.03 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Jun 30, 2025 | 6.96 Mn |
| Jun 30, 2025 | 6.96 Mn |
| Mar 31, 2025 | 1.54 Mn |
| Mar 31, 2025 | 1.54 Mn |
| Dec 31, 2024 | 129,500.00 |
| Dec 31, 2024 | 129,500.00 |
| Sep 30, 2024 | 3.03 Mn |
| Sep 30, 2024 | 3.03 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 999,969.00 |
| Mar 31, 2024 | 999,969.00 |
| Dec 31, 2023 | 1.08 Mn |
| Dec 31, 2023 | 1.08 Mn |